Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future Directions
- 3 May 2017
- journal article
- research article
- Published by Springer Nature in Current Breast Cancer Reports
- Vol. 9 (2) , 111-121
Abstract
Purpose of Review Breast cancer-related lymphedema (BCRL) is a chronic, adverse, and much feared complication of breast cancer treatment, which affects approximately 20% of patients following breast cancer treatment. BCRL has a tremendous impact on breast cancer survivors, including physical impairments and significant psychological consequences. The intent of this review is to discuss recent studies and analyses regarding the risk factors, diagnosis, prevention through early screening and intervention, and management of BCRL. Recent Findings Highly-evidenced risk factors for BCRL include axillary lymph node dissection, lack of reconstruction, radiation to the lymph nodes, high BMI at diagnosis, weight fluctuations during and after treatment, subclinical edema within and beyond 3 months after surgery, and cellulitis in the at-risk arm. Avoidance of potential risk factors can serve as a method of prevention. Through establishing a screening program by which breast cancer patients are measured pre-operatively and at follow-ups, are objectively assessed through a weight-adjusted analysis, and are clinically assessed for signs and symptoms, BCRL can be tracked accurately and treated effectively. Management of BCRL is done by a trained professional, with research mounting towards the use of compression bandaging as a first line intervention against BCRL. Finally, exercise is safe for breast cancer patients with and without BCRL and does not incite or exacerbate symptoms of BCRL. Summary Recent research has shed light on BCRL risk factors, diagnosis, prevention, and management. We hope that education on these aspects of BCRL will promote an informed, consistent approach and encourage additional research in this field to improve patient outcomes and quality of life in breast cancer survivors.Keywords
Funding Information
- National Cancer Institute (R01CA139118, P50CA08393)
This publication has 74 references indexed in Scilit:
- Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitisThe Lancet Oncology, 2016
- Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical TrialAnnals of Surgical Oncology, 2016
- Establishing and Sustaining a Prospective Screening Program for Breast Cancer-Related Lymphedema at the Massachusetts General Hospital: Lessons LearnedJournal of Personalized Medicine, 2015
- Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)The Lancet, 2015
- Recent progress in the treatment and prevention of cancer‐related lymphedemaCA: A Cancer Journal for Clinicians, 2014
- Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?Breast Cancer Research and Treatment, 2013
- Preventative Measures for Lymphedema: Separating Fact from FictionJournal of the American College of Surgeons, 2011
- Lymphedema and Quality of Life in Breast Cancer Survivors: The Iowa Women's Health StudyJournal of Clinical Oncology, 2008
- Lymphedema managementSeminars in Radiation Oncology, 2003
- The grading of lymphedema in oncology clinical trialsSeminars in Radiation Oncology, 2003